Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
NurExone Biologic: Technisches (täglich, wöchentlich, monatlich) & Analysten "Strong Buy"-Rating!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
687 Leser
Artikel bewerten:
(2)

Application for Admission - Sativa Wellness Group Inc.

DJ Application for Admission - Sativa Wellness Group Inc.

Aquis Stock Exchange (AQSE) 
Application for Admission - Sativa Wellness Group Inc. 
 
02-Sep-2020 / 15:00 GMT/BST 
Dissemination of a Regulatory Announcement, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
 
  ANNOUNCEMENT OF APPLICATION FOR ADMISSION TO THE AQSE GROWTH 
                             MARKET 
 
APPLICANT NAME: 
Sativa Wellness Group Inc. 
 
APPLICANT REGISTERED OFFICE, PRINCIPLE PLACE OF BUSINESS (IF 
DIFFERENT) AND TELEPHONE NUMBER: 
The Company's registered office is 503 - 905 West Pender Street, 
Vancouver, BC V6C 1L6, Canada and the principal place of 
business is The Blue Building Stubbs Lane, Beckington, Frome, 
Somerset, BA11 6TE, United Kingdom. 
 
Telephone: +44 (0) 20 7971 1255 
 
DIRECTORS AND PROPOSED DIRECTORS (IF APPLICABLE): 
Henry Lees-Buckley: Chief Executive Officer and Director 
 
Mr. Lees-Buckley is a seasoned corporate executive, with 
extensive experience of leading companies in the public markets. 
Mr. Lees-Buckley was previously CEO of Uni-Select, a Canadian 
TSX quoted company, with operations in the UK, Canada and the 
USA. Prior to that, he was a senior global executive and officer 
in the USA and Canada for W.W. Grainger, a US$15 billion Fortune 
500 company. He is currently a non-Executive Director of 
NASDAQ-quoted BMC (Building Materials Corp) which has sales of 
US$3.8 billion and a market capitalization of US$1.6 billion. 
Mr. Lees-Buckley holds an MBA from Queens University, Kingston, 
Ontario and has held numerous executive level positions both in 
North America and the United Kingdom. 
 
Joseph Colliver, Chief Financial Officer and Director 
 
Joseph is a Chartered Accountant with a track record in 
financial and statutory reporting, strategy, commercial finance, 
management consultancy and regulatory compliance. Joseph is 
accountable for the financial, statutory and regulatory 
reporting associated with a publicly listed company, and 
performs a Group leadership role as one of two executive board 
directors. Joseph has worked across the health & wellness, 
consumer goods, retail, marketing, market research and financial 
services sectors. Previously a Director of Consulting at Kantar 
Consulting, part of WPP Plc ("WPP") which advises Retail, Sales 
and Shopper clients on enhancing their commercial capability and 
the commercial competency of their staff. Prior to this, Joseph 
was CFO and a senior board member at WPP's Kantar Futures. From 
2012 - 2015 Joseph was Global Commercial Director of WPP's 
Kantar subsidiary Taylor Nelson Sofres, a $1.8 billion turnover 
marketing agency. 
 
Jonathan Wearing, Chairman of the Board of Directors 
 
Jonathan is an experienced, City-based corporate financier, who 
began his City career after graduating from Cambridge University 
with a M.A. in Economics. Formally a Director in the corporate 
finance department of Citicorp Investment Bank Limited, Jonathan 
is currently an angel investor in companies. He was also 
Chairman of Ideagen Plc from July 2012 until April 2018 and 
remained a non-Executive Director until November 2019. 
 
Angus Kerr - Non-Executive Director 
 
Angus is an adviser and capital markets professional with nearly 
25 years' experience in global banking with specific expertise 
in strategic and equity advisory, M&A and ECM. He has held, 
inter alia, managing director and management roles covering 
advisory, equity advisory and ECM at a number of organisations, 
including head of Mid-Market Advisory and Broking at Credit 
Suisse and head of UK ECM at Dresdner Kleinwort. He has a long 
track record of advising companies and high-profile individuals 
in the UK, USA and Europe. He is currently Chairman of North 
Berwick SA. 
 
Mark Blower, Director 
 
Mark is an experienced finance professional, having spent the 
last 20 years actively overseeing the financial performance of 
over 70 UK SME's, with a focus on raising debt and private 
equity. He began his career in 1996 at the Investment Banking 
division of a large UK bank, before joining NM Rothschild in 
2000. He then ran a highly successful leveraged debt team for 
five years before starting his Private Equity career in 2010. 
During his career to-date he has held a number of board 
positions, across a variety of sectors. 
 
Jason Dussault, Director 
 
Jason will devote a minority of his working time to the Company 
in connection with his duties as a director of the Company. 
Jason is a man of many talents with a mind for marketing and 
creativity. He produced and starred in "Dussault Inc.", a 
reality television show that aired on City TV, and created a 
successful fashion brand with Gene Simmons and Criss Angel 
called "Dussault Apparel". Jason's professional journey has 
primarily been focused on mining and capital markets. His debut 
in the global marketplace occurred during the exploration boom 
in the North West Territories, which lasted for nearly two 
decades. However, Jason has also worked with a number of 
wireless, high-tech, retail and energy start-ups, and has 
specifically devoted his past two years on strategic minerals, 
focusing primarily on lithium in Nevada. Jason's unique passion 
for both business and art has made him an individual of great 
effectiveness and creativity. Jason's success in artwork include 
completing a mosaic team emblem for FC Barcelona, a community 
created pieces titled "Barker Evergreen" in association with 
Telus which is displayed at one of Canada's most celebrated 
venues, the Pacific National Exhibition. Jason is also 
represented by the Hoerle-Guggenheim Contemporary Art Gallery, 
New York and at the Maddox Gallery in Mayfair, London. Jason has 
previously acted as director and CEO of Pure Energy Minerals 
Limited and Zadar Ventures Ltd. 
 
Anne Tew, Corporate Secretary 
 
Anne is an experienced qualified Accountant, Company Secretary, 
and business Mentor who has worked in a range of sectors 
including the NHS, technology, lab research, manufacturing, 
farming and education to achieve business turnaround, growth and 
development. Anne has worked as an Executive and Non-Executive 
Director as well as advising board members in financial and 
governance matters as the Company Secretary or external 
consultant. 
 
APPLICANT SECTOR: 
Pharmaceuticals and Biotechnology 
 
DESCRIPTION OF THE APPLICANT AND ITS ACTIVITIES: 
Sativa Wellness (Canadian Securities Exchange: STIL), is a fully 
integrated European seed to consumer CBD group with the pricing, 
products, and stability to meet the CBD market demand in the 
medium term. With world-class extraction and formulation 
experts, an agricultural team that has over 20 years' experience 
farming hemp, along with laboratory testing capabilities, the 
group has established itself globally as a trusted source of 
high-grade, premium wholesale CBD brands and products. 
 
The Company is pleased to announce that it has today applied for 
admission of its entire issued share capital of 302,594,773 
common shares, having no par value ("Common Shares") to trading 
on the AQSE Growth Market ("AQSE"). Admission is expected to 
take place on or around 16 September 2020. 
 
Admission is conditional on the Scheme of Arrangement becoming 
effective which is expected to take place on or around 1 
September 2020, and conditional upon Sativa Wellness (name 
changed from Stillcanna Inc.) being readmitted to the Canadian 
Securities Exchange ("CSE"), pursuant to the acquisition of 
Sativa Group plc. The Scheme of Arrangement was entered into 
whereby Stillcanna Inc. acquired Sativa Group plc in an all 
share exchange. The acquisition becomes effective, whereby 
former shareholders of Sativa Group plc will become shareholders 
of approximately 65 per cent. and Stillcanna shareholders will 
become shareholders of approximately 35 per cent. including all 
option and warrant instruments outstanding on a fully diluted 
basis, of the now combined Sativa Wellness. 
 
The merger of Sativa Group and Stillcanna brings together 
expertise that cover all stages of the product development 
lifecycle, from seed through to cultivation and extraction, and 
now testing, bottling and distribution. 
 
For the avoidance of doubt, the Company will remain listed, with 
its Common Shares trading on the CSE following admission to the 
AQSE Growth Market. The Common Shares will continue to trade on 
the OTC and the FSE. The Company will have a dual listing with 
its Common Shares fully fungible through a Depositary Interest 
("DI"). The DIs will carry the same ISIN as the Common Shares 
listed in Canada on the CSE. The ISIN number is CA86071P1071. 
 
Company Information 
 
Stillcanna Shares were initially admitted to trading on the 
TSX-V in Toronto on 2 May 2012 and were subsequently delisted on 
21 September 2015 when the Stillcanna Shares were admitted to 
trading on the CSE. The Stillcanna Shares were subsequently 
quoted on the OTC Pink on 31 May 2019 and on the FSE on or 
around 1 March 2019. On 15 March 2019, Stillcanna changed its 
business from being a mining company to a life science company. 
 
The Company's common shares is expected to be admitted to 
trading on the Canadian Securities Exchange on or around 16 
September 2020, having acquired the entire issued share capital 
of Sativa Group plc. 
 
Sativa, through its subsidiaries, operates five separate 
businesses: Goodbody Botanicals, Sativa's primary retail 
subsidiary which sells CBD products online and on the high 
street; Goodbody Wellness, Sativa's high street retail store 
offering and prestige CBD wellness centre brand; Tessellate 
Collective, a bespoke direct sales channel operated through a 
custom-built social marketing platform; PhytoVista Laboratories, 
an independent analytical hemp and CBD testing facility 
providing support to retailers, distributers and manufacturers 
by expertly testing the cannabinoid level of the hemp and CBD 
products they are supplying and also for contaminants; and 
Sativa Cultivation and Extraction, which cultivates and extracts 
high THC medicinal cannabis under Home Office licence for 
research purposes, to fulfil its research partnership with 

(MORE TO FOLLOW) Dow Jones Newswires

September 02, 2020 10:00 ET (14:00 GMT)

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2020 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.